Operations Research Advances Cancer Therapeutics

Published Online:https://doi.org/10.1287/inte.1070.0327

References

  • American Cancer Society Cancer facts and figures. (2006) . American Cancer Society, AtlantaGoogle Scholar
  • Anderson L. L. Planning optimization and dose evaluation in brachytherapy. Sem. Radiation Oncology (1993) 3:290–300CrossrefGoogle Scholar
  • Bixby R. E., Lee E. K. Solving a truck dispatching scheduling problem using branch-and-cut. (1993) . Doctoral dissertation, Rice University, HoustonGoogle Scholar
  • Bixby R. E., Lee E. K. Solving a truck dispatching scheduling problem using branch-and-cut. Oper. Res. (1998) 46(3):355–367LinkGoogle Scholar
  • Blasko J. C., Ragde H., Luse R. W., Sylvester J. E., Cavanagh W., Frimm P. D. Should brachytherapy be considered a therapeutic option in localized prostate cancer? Urologic Clinics North Amer. (1996) 23:633–650CrossrefGoogle Scholar
  • Cornuéjols G., Dwande M. A class of hard small 0-1 programs. INFORMS J. Comput. (1999) 11(2):205–210LinkGoogle Scholar
  • Easton T., Hooker K., Lee E. K. Facets of the independent set polytope. Math. Programming B (2003) 98:177–199CrossrefGoogle Scholar
  • Gallagher R. J., Lee E. K., Masys D. R. Mixed integer programming optimization models for brachytherapy treatment planning. Proc. 1997 Amer. Medical Informatics Assoc. Annual Fall Sympos. (1997) Nashville, TN:278–282Google Scholar
  • Kleinberg L., Wallner K., Zelefsky M., Arterbery V. E., Fuks Z., Harrison L. Treatment related symptoms during the first year following transperineal 125I prostate implantation. Internat. J. Radiation Oncology Biol. Phys. (1994) 28:985–990CrossrefGoogle Scholar
  • Kutcher G. J., Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Internat. J. Radiation Oncology Biol. Phys. (1989) 16:1623–1630CrossrefGoogle Scholar
  • Lee E. K., Maheshwary S. Facets of conflict hypergraphs. Math. Oper. Res. (2008) . In reviewGoogle Scholar
  • Lee E. K., Zaider M. Determining an effective planning volume for permanent prostate implants. Internat. J. Radiation Oncology Biol. Phys. (2001a) 49(4):1197–1206CrossrefGoogle Scholar
  • Lee E. K., Zaider M. Intraoperative iterative treatment-plan optimization for prostate implants. 2nd Internat. Innovative Solutions for Prostate Cancer Care Meeting (2001b) Coronado Island, CA:32–33Google Scholar
  • Lee E. K., Zaider M. Mixed integer programming approaches to treatment planning for brachytherapy—Application to permanent prostate implants. Ann. Oper. Res. (2003a) 119:147–163CrossrefGoogle Scholar
  • Lee E. K., Zaider M. Intra-operative dynamic dose optimization in permanent prostate implants. Internat. J. Radiation Oncology Biol. Phys. (2003b) 56(3):854–861CrossrefGoogle Scholar
  • Lee E. K., Zaider M. Incorporating biological metabolite information within treatment of prostate carcinoma. Internat. J. Radiation Oncology Biol. Phys. (2004) 60(1):S370–S371CrossrefGoogle Scholar
  • Lee E. K., Zaider M. Incorporating biological metabolite information within treatment of prostate carcinoma and analysis of dose escalation effect. Internat. J. Radiation Oncology Biol. Phys. (2006) 66(3):S572–S573CrossrefGoogle Scholar
  • Lee E. K., Gallagher R., Zaider M. Planning implants of radionuclides for the treatment of prostate cancer: An application of mixed integer programming. Optima, Math. Programming Soc. Newsletter (1999a) 61:1–10Google Scholar
  • Lee E. K., Gallagher R. J., Silvern D., Wuu C. S., Zaider M. Treatment planning for brachytherapy: An integer programming model, two computational approaches and experiments with permanent prostate implant planning. Phys. Med. Biol. (1999b) 44:145–165CrossrefGoogle Scholar
  • Lyman J. T. Complication probabilities as assessed from dose-volume histograms. Radiation Res. (1985) 104:S13–S19CrossrefGoogle Scholar
  • Moerland M. A., Wijrdeman H. K., Beersma R., Bakker C. J., Battermann J. J. Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. Internat. J. Radiation Oncology Biol. Phys. (1997) 37(4):927–933CrossrefGoogle Scholar
  • New York Times Computerized treatment may help prostate cancer. (2001) February 20Google Scholar
  • New York Times Profit and questions as doctors offer prostate cancer therapy. (2006) December 1):A1Google Scholar
  • Prestidge B. R., Bice W. S., Kiefer E. J., Prete J. J. Timing of CT-based post-implant assessment following permanent transperineal prostate brachytherapy. Internat. J. Radiation Oncology Biol. (1998) 40(5):1111–1115CrossrefGoogle Scholar
  • Savelsbergh M. W. P. Preprocessing and probing for mixed integer programming problems. ORSA J. Comput. (1994) 6:445–454LinkGoogle Scholar
  • Silvern D. A. Automated OR prostate brachytherapy treatment planning using genetic optimization. (1998) . Doctoral dissertation, Columbia University, New YorkGoogle Scholar
  • Silvern D., Lee E. K., Gallagher R. J., Stabile L. G., Ennis R. D., Moorthy C. R., Zaider M. Treatment planning for permanent prostate implants: Genetic algorithm versus integer programming. Medical Biol. Engrg. Comput. (1997) 35:850Google Scholar
  • Sloboda R. S. Optimization of brachytherapy dose distributions by simulated annealing. Medical Phys. (1992) 19:955–964CrossrefGoogle Scholar
  • Wallner K., Roy J., Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J. Clinical Oncology (1996) 14:449–453CrossrefGoogle Scholar
  • Wallner K., Lee H., Wasserman S., Dattoli M. Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection. Internat. J. Radiation Oncology Biol. Phys. (1997) 37:565–569CrossrefGoogle Scholar
  • Waterman F. M., Dicker A. P. Effect of postimplant edema on the rectal dose in prostate brachytherapy. Internat. J. Radiation Oncology Biol. Phys. (1999) 45:571–576CrossrefGoogle Scholar
  • Waterman F. M., Yue N., Corn B. W., Dicker A. P. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on postimplant dosimetry: An analysis based on serial CT aquisition. Internat. J. Radiation Oncology Biol. Phys. (1998) 41:1069–1077CrossrefGoogle Scholar
  • Waterman F. M., Yue N., Reisinger S., Dicker A. P., Corn B. W. Effect of edema on the postimplant dosimetry of an I-125 prostate implant: A case study. Internat. J. Radiation Oncology Biol. Phys. (1997) 38:335–339CrossrefGoogle Scholar
  • Wei J. T., Dunn R. L., Sandler H. M., McLaughlin P. W., Montie J. E., Litwin M. S., Nyquist L., Sanda M. G. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J. Clinical Oncology (2002) 20(2):557–566CrossrefGoogle Scholar
  • Yu Y., Schnell M. C. A genetic algorithm for optimization of prostate implants. Medical Phys. (1996) 23:1085–1091CrossrefGoogle Scholar
  • Yue N., Dicker A. P., Nath R., Waterman F. M. The impact of edema on planning 125I and 103Pd prostate implants. Medical Phys. (1999a) 26(5):763–767CrossrefGoogle Scholar
  • Yue N., Dicker A. P., Corn B. W., Nath R., Waterman F. M. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of I-125 or Pd-103 seed implant of prostate. Internat. J. Radiation Oncology Biol. Phys. (1999b) 43:447–454CrossrefGoogle Scholar
  • Zaider M., Leibel S. A., Phillips T. L. Aspects of brachytherapy physics. Textbook of Radiation Oncology (2003) 2nd ed.(Saunders, Philadelphia) Google Scholar
  • Zaider M., Zelefsky M. J., Lee E. K., Zakian K. L., Amols H. I., Dyke J., Cohen G., Hu Y. C., Endi A. K., Chui C. S., Koutcher J. A. Treatment planning for prostate implants using magnetic resonance spectroscopy imaging. Internat. J. Radiation Oncology Biol. Phys. (2000) 47:1085–1096CrossrefGoogle Scholar
  • Zelefsky M. J., Whitmore W. F. Long term results of retropubic permanent 125-iodine implantation of the prostate for clinically localized prostatic cancer. J. Urology (1997) 158:23–29CrossrefGoogle Scholar
  • Zelefsky M. J., Hollister T., Raben A., Matthews S., Wallner K. E. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Internat. J. Radiation Oncology Biol. Phys. (2000a) 47(5):1261–1266CrossrefGoogle Scholar
  • Zelefsky M. J., Yamada Y., Cohen G. N., Shippy A., Chan H., Fridman D., Zaider M. Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer. Internat. J. Radiation Oncology Biol. Phys. (2007) 67(1):65–70CrossrefGoogle Scholar
  • Zelefsky M. J., Yamada Y., Cohen G., Venkatraman E. S., Fung A. Y. C., Furhang E., Silvern D., Zaider M. Postimplantation dosimetric analysis of permanent transperineal prostate implantation: Improved dose distribution with an intraoperative computer optimized conformal planning technique. Internat. J. Radiation Oncology Biol. Phys. (2000b) 48:601–608CrossrefGoogle Scholar
  • Zelefsky M. J., Yamada Y., Marion C., Sim S., Cohen G., Ben-Porat L., Silvern D., Zaider M. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Internat. J. Radiation Oncology Biol. Phys. (2003) 55(4):956–963CrossrefGoogle Scholar
  • Zelefsky M. J., Wallner K. E., Ling C. C., Raben A., Hollister T., Wolfe T., Grann A., Gaudin P., Fuks Z., Leibel S. A. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J. Clinical Oncology (1999) 17(2):517–522CrossrefGoogle Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.